Spanish-Swiss Pharmaceutical Alliance for Eurasian Expansion

ACIR Southern Europe has formalized a collaboration agreement with a prominent Spanish-Swiss pharmaceutical company, present in 47 countries and a leader in molecule development. This partnership enables project launches and expansion across various Eurasian countries with an integrated, sustainable approach.

Eduard Gulián, President of ACIR, held strategic meetings in Madrid with this and other international companies interested in working together in new markets. As part of the agreement, ACIR will provide access to its financial tools, trade insurance services, and legal framework — essential components for project success.

Multidisciplinary Working Groups

To tackle all aspects of the project, multidisciplinary working groups will be created. These will include experts in pharma regulation, logistics, insurance, technology, and international marketing. This structure will support project adaptation to each Eurasian country’s local conditions and ensure timely implementation.

ACIR continues to position itself as a strategic bridge between Southern Europe and Central Asia, delivering concrete opportunities for globally minded companies.